Clinical trial
Paxerol™ (a Novel Formulation of Acetaminophen and Ibuprofen) for Treatment of Nocturia - A Phase II Placebo-Controlled Trial
NCT02646826 is registered in ClinicalTrials.gov with Wellesley Pharmaceuticals, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Paxerol™ (a Novel Formulation of Acetaminophen and Ibuprofen) for Treatment of Nocturia - A Phase II Placebo-Controlled Trial
- Lead sponsor
- Wellesley Pharmaceuticals, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- November 30, 2017
- Enrollment
- 86 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.